FIELD: medicine biologically active additives.
SUBSTANCE: According to the invention, the immunobiological bactericidal preparation contains species-specific virulent bacteriophages and induced-virulence bacteriophages of Appelman's lytic activity at least 10-4 with respect to test strains and bacteria isolates recovered from a human body in filtrate, concentrate filtrate or in a dry biomass of a phage lysate filtrate of nonlysogenic bacteria and pharmaceutically acceptable desired additives. The preparation can be presented as ointment, suppository, powder, tablet or capsule. Declared immunobiological bactericidal preparation is prepared by sequential multiple passages of phages of bacteriophage preparations through test strains and nonlysogenic bacteria isolates fresh-recovered from a human body with an inducing agent, eg mitomycin C, added to nutrient medium. According to the invention, the immunobiological bactericidal preparation provides stable virulence of bacteriophages and adaptation thereof to circular agents of bacterial infections.
EFFECT: higher clinical effectiveness.
13 cl, 9 tbl, 30 ex
Title | Year | Author | Number |
---|---|---|---|
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
IMMUNOBIOLOGICAL ANTIALLERGIC AGENT (VERSIONS) AND Lactobacillus acidophilus 100 "аш" PA STRAIN USED FOR PRODUCTION OF IMMUNOBIOLOGICAL ANTIALLERGIC AGENT | 2008 |
|
RU2431663C2 |
ORAL COMPOSITION CONTAINING NONPATHOGENIC MICROORGANISMS SHOWING ABILITY TO NORMALISE INTESTINAL MICROFLORA (VERSIONS) | 2008 |
|
RU2453320C2 |
ANTIBACTERIAL COMPOSITION, STRAIN OF BACTERIOPHAGE Escherichia coli, USED FOR OBTAINING THEREOF | 2012 |
|
RU2518303C2 |
PREPARATION CONTAINING STAPHYLOCOCCAL BACTERIOPHAGE, AS PREPARATION FOR CANDIDIASIS TREATMENT | 2008 |
|
RU2377006C1 |
ANTIBACTERIAL COMPOSITION IN FORM OF SUPPOSITORY AND METHOD OF ITS PREPARATION | 2016 |
|
RU2622762C1 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
METHOD OF TREATMENT OF INFECTION RELATED TO THE PROVISION OF MEDICAL ASSISTANCE CAUSED BY A CAUSATIVE AGENT OR PATHOGENS WITH MULTIPLE DRUG RESISTANCE | 2017 |
|
RU2664681C1 |
BIOPHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL AND PROBIOTIC ACTIVITY AND DOSAGE FORM BASED ON IT | 2021 |
|
RU2795770C2 |
ANTIBACTERIAL AGENT BASED ON BACTERIOPHAGE | 2017 |
|
RU2672869C1 |
Authors
Dates
2009-09-10—Published
2007-10-29—Filed